Coldstream Capital Management Inc Cullinan Oncology, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 207 shares of CGEM stock, worth $1,711. This represents 0.0% of its overall portfolio holdings.
Number of Shares
207Holding current value
$1,711% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CGEM
# of Institutions
153Shares Held
66.4MCall Options Held
32.6KPut Options Held
22.2K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$63.3 Million13.93% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$47.6 Million2.62% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$29.4 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$28.2 Million15.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.38MShares$27.9 Million1.02% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $377M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...